BEAM FY 2018 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$34M

Operating Income

-$46M

Net Income

-$115M

EPS (Diluted)

$-3.28

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$33M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$167M

Total Liabilities

$33M

Stockholders' Equity

$134M

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$34M	$0	—
Operating Income	-$46M	-$9M	-432.1%
Net Income	-$115M	-$9M	-1220.3%